返回
摘要
En 中文
Purpose of review The purpose of this review is to summarize the recent advances in Takayasu arteritis (TAK), mainly focusing on pathogenesis, imaging modalities, and management. Recent findings Three novel clusters based on angiographic findings were identified in the Indian cohort and replicated in the North American cohorts. Different new imaging modalities have been tried in the assessment of arterial inflammation with promising results. There is more evidence on the long-term use of tocilizumab, but relapses are common. In light of the recent findings on the pathogenesis of TAK, Janus kinase inhibitors seem to be promising. Summary Improvement in imaging modalities and in our understanding of the disease pathogenesis will allow us to better assess the disease activity and identify effective therapeutic agents.
Keyword:
biomarker
imaging modalities
large vessel vasculitis
management
Takayasu arteritis
期刊
IF:
4.3
论文数:
2.2K
被引数:
5.2K
机构
引用论文
A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice
CLINICAL SCIENCE
IF7.7
Tracking Pastoralist Migration: Lessons from the Ethiopian Somali National Regional State追踪游牧民迁徙:来自埃塞俄比亚索马里民族区域州的经验教训
Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population
JOINT BONE SPINE
IF4.3

